Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleRAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications.AuthorsGarcia-Gomez, Antonio; Ocio, Enrique M.; Pandiella, Atanasio; San Miguel, Jesús F.; Garayoa, MercedesPublicationInvestigational New Drugs, 2013, Vol 31, Issue 1, p200ISSN0167-6997Publication typeArticleDOI10.1007/s10637-012-9845-3